Quarterly ResultAug 5, 2026, 04:17 PM
Clover Health Q2 GAAP Net Income $28M; Raises FY26 Guidance
AI Summary
Clover Health reported strong second quarter 2026 financial results, achieving a GAAP Net Income of $28 million, a $39 million improvement year-over-year. The company saw significant growth with total revenues up 56% to $743 million and Medicare Advantage membership increasing 48% to 157,309. Building on this performance, Clover Health raised its full-year 2026 guidance across all key metrics, including total revenues, consolidated gross profit, Adjusted EBITDA, and GAAP Net Income, citing strengthening business performance and an increasing confidence for 2027.
Key Highlights
- Q2 2026 GAAP Net Income was $28 million, an improvement of $39 million year-over-year.
- Q2 2026 Total revenues increased 56% year-over-year to $743 million.
- Q2 2026 Medicare Advantage membership grew 48% year-over-year to 157,309.
- Q2 2026 Adjusted EBITDA rose 139% year-over-year to $41 million.
- Full Year 2026 Total revenues guidance raised to $2.92 billion - $3.00 billion.
- Full Year 2026 Adjusted EBITDA guidance raised to $70 million - $85 million.
- Full Year 2026 GAAP Net Income guidance raised to $20 million - $35 million.
- Full Year 2026 Consolidated Gross Profit guidance raised to $525 million - $555 million.
Price Impact
More from CLOV